info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Blue Biotechnology Companies

Blue biotechnology refers to the use of marine organisms, often microorganisms and other marine resources, for various applications in biotechnology. Companies in the blue biotechnology sector explore the potential of marine life for the development of new products, technologies, and solutions.

Blue Biotechnology Key CompaniesLatest Blue Biotechnology Companies Update



  • Oct 2023: Acasti Pharma Inc. has sold krill-related patents, pre-clinical and clinical research, and processing equipment to Aker BioMarine ASA, consolidating intellectual property (IP) in the krill domain. Originally founded to develop a krill oil medication called CaPre, Acasti Pharma was a division of Neptune Technologies & Bioresources Inc., a Canadian krill oil industry pioneer. A second Phase III experiment (TRILOGY 1) revealed a large placebo effect, although CaPre's Phase II trial findings for lowering triglyceride levels were beneficial. Nevertheless, combining data from TRILOGY 1 and TRILOGY 2 showed a substantial therapeutic impact of more than 10%, with a 26% drop in blood triglyceride levels, as opposed to 15.1% in the placebo group (12-week intervention). These outcomes continued through week 26 of the study.




  • April 2023: The United States Department of Agriculture Animal and Plant Health Inspection Service conducted a pre-market regulatory status evaluation and found that a teff that has undergone genome editing to achieve a semi-dwarf height is exempt from biotechnology regulation under the USDA's SECURE Rule. To increase teff production through innovative plant breeding methods, scientists from the Donald Danforth Plant Science Center's Institute for International Crop Improvement (IICI) collaborated with the Ethiopian Institute of Agricultural Research to create the novel semi-dwarf teff.


List of Blue Biotechnology Key companies in the market


  • Aker BioMarine




  • Marinova




  • New England Biolabs




  • PML Applications Ltd.




  • Sea Run Holdings, Inc.




  • PICES




  • Donald Danforth Plant Science Center




  • Shell Marine Products




  • GeoMarine Biotechnologies




  • GlycoMar




  • Cellgen Biologicals Pvt Ltd.




  • Nurture Aqua Technology Pvt. Ltd.




  • Samudra Biopharma Pvt. Ltd




  • Sanosil Biotech



Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.